Stockreport

Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder [Yahoo! Finance]

Clearmind Medicine Inc. - Common Shares  (CMND) 
PDF the "Company"), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health pr [Read more]